U.S. Physical Therapy, Inc. Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 3/17/2026)
| Balance Sheet | Total Assets | 1,204,010,000.00 | ROE | 39.57 % |
| Balance Sheet | Total Equity | 476,432,000.00 | ROA | 3.29 % |
| Cashflow | Capital Expenditures | -14,071,000.00 | P/FCF | 21.13 |
| Cashflow | Free Cash Flow | 60,987,000.00 | – | – |
| Cashflow | Operating Cash Flow | 75,058,000.00 | P/CF | 17.17 |
| Income | Earnings per Share (diluted) | 1.42 | Div. Yield | 2.12 % |
| Income | Net Income | 39,583,000.00 | P/E | 59.80 |
| Income | Shares Outstanding | 15,175,000.00 | P/B | 2.70 |
| Income | Total Revenue | 780,990,000.00 | P/S | 1.65 |
Ratios calculated on: 10/14/2026
Company Description
U.S. Physical Therapy, Inc. through its subsidiaries, operates outpatient physical and occupational therapy clinics that provides pre- and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. The Company also operates two clinics, which specialize in the outpatient, non-surgical treatment of osteo arthritis degeneration joint disease and other musculoskeletal conditions and perform certain services on behalf of third parties that provide physical therapy services. In May 2013, the Company acquired an 80% interest in a five clinic physical therapy group. In October 2013, U.S. Physical Therapy Inc announced that it has sold the remaining piece of its former Physician Services business.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.corporate.usph.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more